Biological Mechanisms of COVID-19 Acute Respiratory Distress Syndrome
Am J Respir Crit Care Med
.
2020 Dec 1;202(11):1489-1491.
doi: 10.1164/rccm.202009-3629ED.
Authors
Michael A Matthay
1
,
Aleksandra Leligdowicz
1
2
,
Kathleen D Liu
1
Affiliations
1
Department of Medicine, and, Department of Anesthesia, University of California, San Francisco, San Francisco, California and.
2
Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada.
PMID:
32997945
PMCID:
PMC7706166
DOI:
10.1164/rccm.202009-3629ED
No abstract available
Publication types
Editorial
Comment
MeSH terms
Biological Products*
COVID-19*
Humans
Immunity
Pandemics
Patients
Respiratory Distress Syndrome*
SARS-CoV-2
Substances
Biological Products
Grants and funding
K24 DK113381/DK/NIDDK NIH HHS/United States
R35 HL140026/HL/NHLBI NIH HHS/United States
U01 HL123004/HL/NHLBI NIH HHS/United States